Planned US trial of NBTXR 3 intratumoral implant (activated by radiotherapy) for the treatment of cancer
Latest Information Update: 29 Nov 2012
At a glance
- Drugs Hafnium oxide (Primary)
- Indications Cancer
- Focus Therapeutic Use
- 29 Nov 2012 New trial record